NO20033800L - Karbamidforbindelser for bruk ved prevensjon eller terapi av angstlidelser - Google Patents

Karbamidforbindelser for bruk ved prevensjon eller terapi av angstlidelser

Info

Publication number
NO20033800L
NO20033800L NO20033800A NO20033800A NO20033800L NO 20033800 L NO20033800 L NO 20033800L NO 20033800 A NO20033800 A NO 20033800A NO 20033800 A NO20033800 A NO 20033800A NO 20033800 L NO20033800 L NO 20033800L
Authority
NO
Norway
Prior art keywords
group
anxiety disorders
phenyl
alkyl
therapy
Prior art date
Application number
NO20033800A
Other languages
English (en)
Norwegian (no)
Other versions
NO20033800D0 (no
Inventor
Carlos R Plata-Salaman
Boyu Zhao
Roy E Twyman
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of NO20033800D0 publication Critical patent/NO20033800D0/no
Publication of NO20033800L publication Critical patent/NO20033800L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20033800A 2001-02-27 2003-08-26 Karbamidforbindelser for bruk ved prevensjon eller terapi av angstlidelser NO20033800L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27168901P 2001-02-27 2001-02-27
US10/081,713 US7078436B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating anxiety disorders
PCT/US2002/005423 WO2002067923A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating anxiety disorders

Publications (2)

Publication Number Publication Date
NO20033800D0 NO20033800D0 (no) 2003-08-26
NO20033800L true NO20033800L (no) 2003-09-26

Family

ID=23036639

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033800A NO20033800L (no) 2001-02-27 2003-08-26 Karbamidforbindelser for bruk ved prevensjon eller terapi av angstlidelser

Country Status (25)

Country Link
US (3) US7078436B2 (de)
EP (1) EP1399144B1 (de)
JP (1) JP2004523554A (de)
KR (1) KR20030078947A (de)
CN (1) CN1503665A (de)
AT (1) ATE324107T1 (de)
AU (1) AU2002306567B2 (de)
BR (1) BR0207830A (de)
CA (1) CA2439286A1 (de)
CY (1) CY1107468T1 (de)
CZ (1) CZ20032311A3 (de)
DE (1) DE60210960T2 (de)
DK (1) DK1399144T3 (de)
ES (1) ES2262826T3 (de)
HU (1) HUP0303262A2 (de)
IL (1) IL157594A0 (de)
MX (1) MXPA03007720A (de)
MY (1) MY136391A (de)
NO (1) NO20033800L (de)
NZ (1) NZ546549A (de)
PL (1) PL364639A1 (de)
PT (1) PT1399144E (de)
RS (1) RS50505B (de)
RU (1) RU2292881C2 (de)
WO (1) WO2002067923A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03007720A (es) * 2001-02-27 2004-11-12 Johnson & Johnson Compuestos de carbamato para su uso en la prevencion o el tratamiento de transtornos de ansiedad.
JP2008528489A (ja) 2005-01-20 2008-07-31 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｑｔ間隔調節方法
ES2435403T3 (es) 2005-06-08 2013-12-19 Sk Biopharmaceuticals Co., Ltd. Tratamiento de trastornos del sueño y vigilia
JP2010508279A (ja) * 2006-10-27 2010-03-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 破壊的行動障害の処置法
US8263652B2 (en) 2007-10-31 2012-09-11 Sk Biopharmaceuticals Co., Ltd. Stabilized pediatric suspension of carisbamate
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
ES2998534T3 (en) 2013-03-12 2025-02-20 Bio Pharm Solutions Co Ltd Phenyl carbamate compounds for use in preventing or treating pediatric epilesy
US9907776B2 (en) 2013-03-12 2018-03-06 Bio-Pharm Solutions, Co., Ltd. Phenyl carbamate compound and a composition for preventing or treating a psychiatric disorder comprising the same
JP6807941B2 (ja) * 2016-02-29 2021-01-06 バイオ−ファーム ソリューションズ カンパニー リミテッド スルファメート誘導体化合物、その製造方法および用途
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
KR102900173B1 (ko) * 2016-12-14 2025-12-12 에스케이바이오팜 주식회사 조현병, 강박장애 및 투렛증후군으로부터 선택되는 정신증 장애의 예방, 경감 또는 치료에 있어서의 카바메이트 화합물의 용도
AU2018278332B2 (en) 2017-06-02 2022-05-19 Jazz Pharmaceuticals Ireland Limited Methods and compositions for treating excessive sleepiness
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3248418A (en) 1962-06-26 1966-04-26 Charles D Bossinger 2-hydroxy-2-phenyl alkyl carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
CN1109880A (zh) * 1994-02-03 1995-10-11 合成实验室公司 3-(2-氨基乙基)-4-[3-(三氟甲基)苯甲酰基]-3，4-二氢-2h-1，4-苯并噁嗪衍生物、制备及其应用
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
CZ302412B6 (cs) 2001-02-27 2011-05-04 Ortho-Mcneil Pharmaceutical, Inc. Lécivo pro prevenci nebo lécbu psychotických chorob
MXPA03007720A (es) * 2001-02-27 2004-11-12 Johnson & Johnson Compuestos de carbamato para su uso en la prevencion o el tratamiento de transtornos de ansiedad.
CA2439475C (en) 2001-02-27 2010-05-18 Carlos R. Plata-Salaman Carbamate compounds for use in preventing or treating bipolar disorder

Also Published As

Publication number Publication date
CN1503665A (zh) 2004-06-09
CY1107468T1 (el) 2012-12-19
AU2002306567B2 (en) 2006-08-17
US20020143053A1 (en) 2002-10-03
US7078436B2 (en) 2006-07-18
PT1399144E (pt) 2006-07-31
DK1399144T3 (da) 2006-07-24
NZ546549A (en) 2007-11-30
EP1399144B1 (de) 2006-04-26
US20050267203A1 (en) 2005-12-01
BR0207830A (pt) 2004-06-22
PL364639A1 (en) 2004-12-13
HK1062270A1 (en) 2004-10-29
RS50505B (sr) 2010-03-02
US20090234003A1 (en) 2009-09-17
RU2292881C2 (ru) 2007-02-10
JP2004523554A (ja) 2004-08-05
NO20033800D0 (no) 2003-08-26
KR20030078947A (ko) 2003-10-08
MXPA03007720A (es) 2004-11-12
DE60210960D1 (de) 2006-06-01
IL157594A0 (en) 2004-03-28
HUP0303262A2 (hu) 2004-01-28
ATE324107T1 (de) 2006-05-15
RU2003128986A (ru) 2005-03-20
CA2439286A1 (en) 2002-09-06
ES2262826T3 (es) 2006-12-01
DE60210960T2 (de) 2006-11-16
WO2002067923A1 (en) 2002-09-06
CZ20032311A3 (cs) 2005-02-16
EP1399144A1 (de) 2004-03-24
YU67903A (sh) 2006-08-17
MY136391A (en) 2008-09-30

Similar Documents

Publication Publication Date Title
YU67703A (sh) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja
MY138156A (en) Carbamate compounds for use in preventing or treating neurodegenerative disorders
NO20080877L (no) Fremgangsmater for behandling av substansrelaterte forstyrrelser
NO20033802L (no) Karbamatforbindelser for anvendelse ved forebygging eller behandling av bipolar forstyrrelse
NO20033800D0 (no) Karbamidforbindelser for bruk ved prevensjon eller terapi av angstlidelser
MY133370A (en) Carbamate compounds for use in preventing or treating bipolar disorders
EA200700642A1 (ru) Способы лечения эпилептогенеза и эпилепсии
MY129312A (en) Carbamate compounds for use in the treatment of pain
NO20030299L (no) Karbamatforbindelser for anvendelse ved prevensjon eller terapi av neuropatisk smerte og cluster- og migrenehodepineassosiert smerte
NO20040176L (no) Karbamatforbindelser for anvendelse ved prevensjon eller terapi av neuropatisk smerte og kluster- og migrenehodepineassosiert smerte
MY136733A (en) Carbamate compounds for use in preventing or treating psychotic disorders
MY136347A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application